Synopsis: Several companies have announced capital expenditure plans for FY26, showing strong investment for future growth. These stocks are focusing on expanding capacity, upgrading technology, and improving efficiency.
Firms across sectors like chemicals, engineering, and textiles are planning capex ranging from a few hundred to several thousand crores. These investments are expected to boost production, support new projects, and improve long-term profitability, making these companies attractive for growth-focused investors.
Here are a few stocks with capital expenditure for the financial year 2026
Deepak Fertilisers & Petrochemicals Corp Limited
With a market capitalization of Rs. 17,259.24 crore, the shares of Deepak Fertilisers & Petrochemicals Corp Limited were currently trading at Rs. 1,367.20 per equity share, down nearly 0.61 percent from its previous day’s close price of Rs. 1,375.60.
Deepak Fertilisers & Petrochemicals Corp Limited reported a capex spend of Rs. 870 crore in the first half of FY26. The company’s two major expansion projects, Dahej with a planned investment of Rs. 1,983 crore and Gopalpur with Rs. 2,675 crore, together amounting to a total capex of Rs. 4,658 crore, are progressing well. Both projects are on track and are expected to be commissioned by the end of FY26.
Deepak Fertilisers & Petrochemicals Corp Limited was founded in 1979 and manufactures industrial chemicals, fertilizers, mining chemicals, and speciality products, serving agriculture, pharmaceutical, mining, and infrastructure sectors with a diversified portfolio and significant presence in India.
SMS Pharmaceuticals Limited
With a market capitalization of Rs. 2,977.67 crore, the shares of SMS Pharmaceuticals Limited were currently trading at Rs. 317.95 per equity share, down nearly 0.47 percent from its previous day’s close price of Rs. 319.45.
SMS Pharmaceuticals Limited is undergoing a significant capex-driven expansion plan. The company is investing Rs. 280 crore in a brownfield expansion project, which is expected to be completed by November 2026, along with an additional Rs. 30 crore earmarked for land acquisition for a future greenfield facility.
Revenue generation from these investments is projected to begin in FY28, reflecting the time required for regulatory approvals and market qualification in regulated markets. Alongside this, SMS Pharma is also enhancing its peptide manufacturing capabilities, with commercialization targeted around FY29.
SMS Pharmaceuticals Limited was established in 1990. SMS Pharmaceuticals is a global manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates across multiple therapeutic categories, exporting to over 75 countries with state-of-the-art manufacturing and R&D facilities.
Epigral Limited
With a market capitalization of Rs. 6,544.54 crore, the shares of Epigral Limited were currently trading at Rs. 1517 per equity share, rising nearly 2.07 percent from its previous day’s close price of Rs. 1486.30.
Epigral Ltd has invested Rs. 236 crore in capex year-to-date, with additional projects beyond FY28 being finalized, including one at the existing complex and another sizable project on newly acquired land. Both initiatives focus on import substitution, strong demand growth, and attractive ROCE.
CPVC and ECH capacity-doubling projects are progressing on schedule. The 19.8 MW wind-solar hybrid plant is also on track. The CT value chain, commissioned in March 2025, is scaling up and expected to deliver significant revenue and profit contributions from Q4 FY26 onward.
Epigral Limited was incorporated in 2007 (formerly Meghmani Finechem). Epigral is a leading Indian manufacturer of chlor-alkali products, speciality chemicals, and derivatives, committed to sustainability and innovation in chemical manufacturing.
Arvind Limited
With a market capitalization of Rs. 9,239.54 crore, the shares of Arvind Limited were currently trading at Rs. 352.50 per equity share, down nearly 0.98 percent from its previous day’s close price of Rs. 356.00.
Arvind Limited plans to allocate Rs. 400-450 crore in capex for FY26, of which Rs. 220 crore has already been invested. The company is also selectively deferring non-critical capital expenditures to maintain liquidity flexibility and ensure stronger financial stability during its ongoing operations and strategic initiatives.
Arvind Limited was founded in 1931 and is India’s largest denim and textile manufacturer, producing fabrics, apparel, and technical textiles with a strong presence in domestic and global apparel markets.
Written By – Nikhil Naik
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Deepak Fertilisers and 3 other stocks with capex of up to ₹4,658 Cr for FY26 to keep an eye appeared first on Trade Brains.